Nicolas Joubert

Tours, 37200, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®).

Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®).

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 13, 2026

Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.

Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.

Journal: Journal of medicinal chemistry

Published: September 05, 2025

Anti-cathepsin D antibody-drug conjugates for the targeted delivery of monomethyl auristatin F and E elicit potent anticancer activity in breast cancer.

Anti-cathepsin D antibody-drug conjugates for the targeted delivery of monomethyl auristatin F and E elicit potent anticancer activity in breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 07, 2025

Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer.

Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 21, 2023

Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.

Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.

Journal: Cell & bioscience

Published: November 08, 2022

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).

Journal: Pharmaceutics

Published: June 29, 2022

Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.

Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.

Journal: European journal of medicinal chemistry

Published: October 20, 2021

Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor.

Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor.

Journal: International journal of molecular sciences

Published: August 07, 2021

Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.

Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.

Journal: Pharmacology & therapeutics

Published: July 26, 2021

Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells.

Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 01, 2021

Antibody-Drug Conjugates: The Last Decade.

Antibody-Drug Conjugates: The Last Decade.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 17, 2020

Antibody-drug conjugates in oncology. New strategies in development

Antibody-drug conjugates in oncology. New strategies in development

Journal: Medecine sciences : M/S

Published: January 07, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026